| http://www.w3.org/ns/prov#value | - Cilengitide is currently in clinical phase III studies for the treatment of glioblastomas and is in phase II studies for the treatment of several other tumor types, including breast cancer, squamous cell cancer, nonsmall cell lung cancer, and melanoma [97, 98].Other drugs targeting integrins include the following agents.Abergrin is a humanized antibody against ??v??3 integrins.
|
